Boston Private Bank & Trust’s PDL BioPharma, Inc. PDLI Stock Holding History

Boston Private Bank & Trust’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$2K	Hold	318	–	–	﹤0.01%	994
2014 Q4	$2K	Hold	318	–	–	﹤0.01%	1074
2014 Q3	$2K	Hold	318	–	–	﹤0.01%	1010
2014 Q2	$3K	Hold	318	–	–	﹤0.01%	933
2014 Q1	$3K	Hold	318	–	–	﹤0.01%	957
2013 Q4	$3K	Hold	318	–	–	﹤0.01%	993
2013 Q3	$3K	Hold	318	–	–	﹤0.01%	924
2013 Q2	$2K	Buy	+318	New	+$2.48K	﹤0.01%	922

Other funds holding PDLI

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Boston Private Bank & Trust's PDLI Position: Q1 2015 in Review

Boston Private Bank & Trust held its PDL BioPharma, Inc. (PDLI) position steady in Q1 2015 at 318 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #994.

Boston Private Bank & Trust first reported a position in PDLI in Q2 2013 and has held it in 8 quarters since. The position peaked at $3K in Q2 2014. 215 funds tracked by Wall St. Rank hold PDLI as of Q1 2015.

Boston Private Bank & Trust held 318 shares of PDL BioPharma, Inc. worth $2K as of Q1 2015.
Boston Private Bank & Trust left its PDL BioPharma, Inc. share count unchanged in Q1 2015.
PDL BioPharma, Inc. made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #994 holding.
Boston Private Bank & Trust first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's PDL BioPharma, Inc. position peaked at $3K in Q2 2014.
215 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.